HEROLD ABELLARD: Open Payments
NPI 1497849350 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,328 in 100 payments from 15 companies in 2025. Trend: 2023 $1,113 · 2024 $2,060 · 2025 $2,328
Food & beverage: $2,328
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $468 |
| Vanda Pharmaceuticals Inc. | 10 | $358 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $268 |
| Otsuka America Pharmaceutical, Inc. | 9 | $240 |
| Collegium Pharmaceutical, Inc. | 14 | $192 |
| Alkermes, Inc. | 5 | $152 |
| Lundbeck LLC | 4 | $123 |
| Vertical Pharmaceuticals, LLC | 5 | $113 |
| Tris Pharma Inc | 5 | $105 |
| Axsome Therapeutics, Inc. | 5 | $87 |
Products named: VRAYLAR, CAPLYTA, ABILIFY MAINTENA, FANAPT, Jornay PM, LYBALVI, HETLIOZ, Relexxii.
Industry payments across NY — which companies pay providers there.
